The superior detection rate of total-body [ < sup > 68 < /sup > Ga]Ga-PSMA-11 PET/CT compared to short axial field-of-view [ < sup > 68 < /sup > Ga]Ga-PSMA-11 PET/CT for early recurrent prostate cancer patients with PSA   & lt;  0.2 ng/mL after radical prostatectomy

CONCLUSIONS: In BCR patients with PSA < 0.2 ng/mL, total-body [68Ga]Ga-PSMA-11 PET/CT not only demonstrated a significantly higher detection rate compared to SAFOV [68Ga]Ga-PSMA-11 PET/CT but also led to significant alterations in treatment regimens.PMID:38514483 | DOI:10.1007/s00259-024-06674-1
Source: Molecular Medicine - Category: Molecular Biology Authors: Source Type: research